FFG

FFG is Austria’s national funding agency, headquartered in Vienna, providing substantial non-dilutive support and selective equity financing to stimulate domestic life science research and development. While it appears in venture-style data sets, FFG functions primarily as a public funding body, which shapes how founders should interact with it: the support model emphasizes grants, programs, and structured calls more than conventional equity rounds. Healthcare interest covers biotech and medical devices, where Austria has clear policy priorities for innovation and translation. AI is not a stated focus.

FFG engages at Pre-Seed, Seed, and Series A stages with checks of $250k to $1M when equity-style instruments are deployed, alongside grants that may reach significantly higher totals through specific programs. The geographic focus is Austria, with strong relevance to founders incorporated or operating substantially in the country and pursuing R&D-intensive work eligible for national or EU-aligned funding pathways. Founders should expect a process closer to a structured public call than a conventional VC pitch, with milestones, reporting, and matching requirements that differ from private investor norms.

Named partners and named portfolio companies are not detailed in the materials reviewed, so this profile reflects limited public information regarding equity-side investments and team contacts. Founders considering FFG should prepare a thorough technical project plan, eligibility analysis, and a strategy for combining FFG funding with private capital to maintain momentum without over-relying on grants. The most productive first engagement is through specific funding programs aligned to the company’s research stage, with clear milestones, deliverables, and an articulated path from publicly supported R&D to a privately financed commercial trajectory.